References
- Alves CH, Pellissier LP, Wijnholds J. The CRB1 and adherens junction complex proteins in retinal development and maintenance. Prog Retin Eye Res. 2014;40:35–52.
- Ehrenberg M, Pierce E, Cox GF, et al. CRB1: one gene, many phenotypes. Semin Ophthalmol. 2013;28(5–6):397–405.
- Hettinga YM, Van Genderen MM, Wieringa W, et al. Retinal dystrophy in 6 young patients who presented with intermediate uveitis. Ophthalmology. 2016;123(9):2043–2046.
- De Jager W, Velthuis H, Prakken BJ, et al. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol. 2003;10(1):133–139.
- Tamm S, Whitcup SM, Gery I, et al. Immune response to retinal antigens in patients with gyrate atrophy and other hereditary retinal dystrophies. Ocul Immunol Inflamm. 2001;9(2):75–84.
- Yoshida N, Ikeda Y, Notomi S, et al. Clinical evidence of sustained chronic inflammatory reaction in retinitis pigmentosa. Ophthalmology. 2013;120(1):100–105.
- Stunkel M, Bhattarai S, Kemerley A, et al. Vitritis in pediatric genetic retinal disorders. Ophthalmology. 2015;122(1):192–199.
- Prete M, Dammacco R, Fatone MC, et al. Autoimmune uveitis: clinical, pathogenetic, and therapeutic features. Clin Exp Med. 2016;16(2):125–136.
- Chen P, Tucker W, Hannes S, et al. Levels of blood CD1c+ mDC1 and CD1chi mDC1 subpopulation reflect disease activity in noninfectious uveitis. Investig Ophthalmol Vis Sci. 2015;56(1):346–352.
- Chen P, Urzua C, Knickelbein JE, et al. Elevated CD1c + myeloid dendritic cell proportions associate with clinical activity and predict disease reactivation in noninfectious uveitis. Investig Opthalmology Vis Sci. 2016;57(4):1765–1772.
- Gupta N, Brown KE, Milam AH. Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration. Exp Eye Res. 2003 Apr;76(4):463–471.
- Hughes EH, Schlichtenbrede FC, Murphy CC, et al. Generation of activated sialoadhesin-positive microglia during retinal degeneration. Investig Opthalmology Vis Sci. 2003;44(5):2229–2234.
- Yoshida N, Ikeda Y, Notomi S, et al. Laboratory evidence of sustained chronic inflammatory reaction in retinitis pigmentosa. Ophthalmology. 2013;120(1):e5–e12.
- Zhao L, Zabel MK, Wang X, et al. Microglial phagocytosis of living photoreceptors contributes to inherited retinal degeneration. EMBO Mol Med. 2015;7(9):1179–1197.
- Rutar M, Natoli R, Chia RX, et al. Chemokine-mediated inflammation in the degenerating retina is coordinated by Müller cells, activated microglia, and retinal pigment epithelium. J Neuroinflammation. 2015;12:8.
- Viringipurampeer I, Bashar AE, Gregory-Evans CY, et al. Targeting inflammation in emerging therapies for genetic retinal disease. Int J Inflam. 2013;2013:1–7.
- Guadagni V, Novelli E, Piano I, et al. Pharmacological approaches to retinitis pigmentosa: a laboratory perspective. Prog Retin Eye Res. 2015;48(1):62–81.
- Ozdemir H, Karacorlu M, Karacorlu S. Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa. Acta Ophthalmol Scan. 2005;83(2):248–251.
- Srour M, Querques G, Leveziel N, et al. Intravitreal dexamethasone implant (Ozurdex) for macular edema secondary to retinitis pigmentosa. Graefe’s Arch Clin Exp Ophthalmol. 2013;251(6):1501–1506.